
Ahren et al. in $16m round for Mogrify
A consortium of investors led by existing backer Ahren Innovation Capital has provided UK biotech business Mogrify with a $16m series-A.
Latest News
NB Renaissance, Chequers to exit Biolchim to trade
US conglomerate J.M. Huber has agreed to buy the Italian specialty fertilizers producer
ArchiMed reaps 4x on Bomi sale to UPS
Deal is first full exit from specialist healthcare investor's maiden mid-market fund
GP Profile: Greenpeak Partners on emerging manager fundraising and specialisation
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Summa opens North American office
Three existing partners will lead the California office, which is the GP’s first beyond Europe
Back to Top